Appointment of consulting firm Farthouat Finance as independent expert in connection with New Gen Holding's proposed takeover bid followed, if necessary, by a squeeze-out, for the shares of Generix Group
May 12 2022 - 12:40PM
Appointment of consulting firm Farthouat Finance as independent
expert in connection with New Gen Holding's proposed takeover bid
followed, if necessary, by a squeeze-out, for the shares of Generix
Group
Appointment of consulting firm
Farthouat Finance as independent expert in
connection with New Gen Holding's proposed takeover bid followed,
if necessary, by a squeeze-out, for the shares of Generix Group
(GENX - FR0010501692)
On April 22, 2022, it was announced that the top management of
Generix Group and Pléiade Investissement and its top managers had
entered into exclusive negotiations with the Montefiore Investment
fund with the objective to conclude an investment protocol
providing for the creation of an ad hoc company ("New Gen Holding")
and the subsequent filing of a takeover bid followed, if necessary,
by a squeeze-out, for the shares of Generix Group, for a price of
9.50 euros per share, including an additional price of 0.50 euro
per share, in the event of a squeeze-out (the
"Offer").
In this context, the Supervisory Board of Generix Group has
decided to appoint, unanimously and on the recommendation of the ad
hoc committee made up of four members of the Supervisory Board
(three of whom are independent), the firm Farthouat Finance,
represented by Mrs. Marie-Ange Farthouat, as independent expert who
will be in charge, in accordance with the provisions of articles
261-1 I, 1°, 2° and 4° and II of the general regulations of the
French Financial Markets Authority (Autorité des marchés
financiers), of delivering a report on the financial conditions of
the proposed Offer.
Negotiations between the parties are proceeding as expected. The
parties will keep the market informed of their progress and the
next steps in the project.
- PR_Appointment of consulting firm Farthouat Finance_EN
Generix (LSE:0JAW)
Historical Stock Chart
From May 2024 to Jun 2024
Generix (LSE:0JAW)
Historical Stock Chart
From Jun 2023 to Jun 2024